Dry powder nebulizer device

Genord , et al. March 22, 2

Patent Grant D752206

U.S. patent number D752,206 [Application Number D/500,220] was granted by the patent office on 2016-03-22 for dry powder nebulizer device. This patent grant is currently assigned to MicroDose Therapeutx, Inc.. The grantee listed for this patent is MicroDose Therapeutx, Inc.. Invention is credited to Jeff DeBoer, Dan Genord.


United States Patent D752,206
Genord ,   et al. March 22, 2016

Dry powder nebulizer device

Claims

CLAIM The ornamental design for a dry powder nebulizer device, as shown and described.
Inventors: Genord; Dan (South Lyon, MI), DeBoer; Jeff (Ann Arbor, MI)
Applicant:
Name City State Country Type

MicroDose Therapeutx, Inc.

Monmouth Junction

NJ

US
Assignee: MicroDose Therapeutx, Inc. (Monmouth Junction, NJ)
Appl. No.: D/500,220
Filed: August 22, 2014

Current U.S. Class: D24/110
Current International Class: 2902
Field of Search: ;D24/107,108,110,110.1,164

References Cited [Referenced By]

U.S. Patent Documents
D191733 November 1961 Schmal
3045670 July 1962 Hirtz
D198487 June 1964 Ferris
3695267 October 1972 Hirtz
D339416 September 1993 Maher
5392768 February 1995 Johansson
D363775 October 1995 Hobbs
5469750 November 1995 Lloyd
D441071 April 2001 Attolini
D444226 June 2001 Geert-Jensen
6283118 September 2001 Lu
D558330 December 2007 Chang
D585977 February 2009 Brown
D687945 August 2013 Brewer
D687946 August 2013 Brewer
D687947 August 2013 Brewer
8511301 August 2013 Nobutani
8616195 December 2013 Power
2006/0000469 January 2006 Tseng
2006/0137682 June 2006 Tseng
2007/0227534 October 2007 Nobutani
2007/0272169 November 2007 Barney
2008/0022998 January 2008 Hamano
2009/0050142 February 2009 Hamano
2009/0107492 April 2009 Ooida
2010/0043792 February 2010 Takei
2010/0154793 June 2010 Kobayashi
2010/0319687 December 2010 Esaki
2012/0160241 June 2012 Oliva
2012/0285452 November 2012 Amirav

Other References

Cook, et al., "Phase 1 Studies of MDT-637: Antiviral Treatment for Respiratory Syncytial Virus Infection," MicroDose Therapeutix, Inc, poster from RSV, 8th Annual Respiratory Syncytial Virus Symposium, Santa Fe, New Mexico, 2012. cited by applicant .
"Teva R&D in Focus--Respiratory." Webinar for the investment community, Oct. 8, 2013, downloaded from http://www.sec.gov/Archives/edgar/data/818686/000115752313004684/a5072508- 5ex99-1.htm. cited by applicant.

Primary Examiner: Fox; Barbara
Assistant Examiner: Bekic; Lilyana
Attorney, Agent or Firm: RatnerPrestia

Description



FIG. 1 is a perspective view from the top, front and right corner of a dry powder nebulizer device;

FIG. 2 is a top plan view thereof;

FIG. 3 is a bottom plan view thereof;

FIG. 4 is a left elevation view thereof;

FIG. 5 is a right elevation view thereof;

FIG. 6 is a front elevation view thereof; and,

FIG. 7 is a rear elevation view thereof.

The broken lines in the drawings illustrate portions of the dry powder nebulizer device which form no part of the claimed design.

* * * * *

References


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed